on behalf of the BiKE and ASAP study groups Background-Population-based genome-wide association studies have identified several single nucleotide polymorphisms (SNPs) associated with cardiovascular disease or its risk factors. Genes in close proximity to these risk-SNPs are often thought to be pathogenetically important based on their location alone. However, the actual connections between SNPs and disease mechanisms remain largely unknown. Methods and Results-To identify novel susceptibility genes, we investigated how 166 SNPs previously found to be associated with increased cardiovascular risk and/or predisposing metabolic traits relate to the expression of nearby genes. Gene expression in 577 samples of aorta, liver, mammary artery, and carotid atherosclerotic plaque was measured using expression arrays. For 47 SNPs, the expression levels of proximal genes (located within 200 kb) were affected (PϽ0.005). More than 20 of these genes had not previously been identified as candidate genes for cardiovascular or related metabolic traits. SNP-associated gene effects were tissue-specific and the tissue specificity was phenotype-dependent.
I t is incompletely understood how single nucleotide polymorphisms (SNPs) mediate their impact on pathobiology. The majority of disease-associated SNPs are located in noncoding regions of the genome. It is therefore speculated that genetic variants in promoter and enhancer regions are likely to affect gene expression levels. Such relations have previously been shown to exist using a candidate-gene driven approach. 1,2 Furthermore, genome-wide studies using gene expression levels as quantitative traits (eQTLs) have indicated a widespread regulation of gene expression by cisacting SNPs. [3] [4] [5] [6] Marked differences in association patterns between different cell types have also been observed in studies using stable cell lines, for example, fibroblasts, T-cells, and immortalized lymphoblastoid cells. In these studies, 69% to 80% of the regulatory variants were identified only in specific cell types. 4 With the exception of 1 study on postmortem liver tissue, 5 the majority of eQTL studies have used readily available cell lines. However, for SNPs associated with a particular disease phenotype, eQTL associations should primarily be detectable in biopsy specimens from tissues known to be involved in the pathogenesis of the disease. We therefore hypothesized that the mechanisms of cardiovascular and metabolic risk-SNPs can be deduced by use of gene expression data from relevant tissues. To this end, we determined the association of risk-SNPs with gene expression levels in samples from liver, aorta (medial and adventitial portions), mammary artery, and carotid plaque obtained from 2 biobanks, each containing more than 200 samples from carotid endarterectomy and aortic valve disease patients, respectively.
Methods

Sample Collection
Biobank materials were generated after informed consent from all participants had been obtained according to the declaration of Helsinki and with approval by the ethics committee of the Karolinska Institute (application numbers 02 to 147 and 2006/784 to 31/1).
The Advanced Study of Aortic Pathology (ASAP) included patients undergoing aortic valve surgery at the Karolinska University Hospital, Stockholm, Sweden. Biopsy specimens were obtained at surgery from liver, mammary artery, and dilated and nondilated ascending aorta. The medial and adventitial layers of the vascular specimens were isolated by adventicectomy, incubated with RNAlater (Ambion, Austin, Tex), and homogenized with a FastPrep (Qbiogene, Irvine, Calif) using Lysing Matrix D tubes (In Vitro Cat. No. 6913-100, Stockholm, Sweden). The Biobank of Karolinska Endarterectomies (BiKE) study included atherosclerotic tissue collected from patients undergoing carotid endarterectomy at the Karolinska University Hospital, Stockholm, Sweden. For both biobanks, total RNA was isolated using Trizol (BRL-Life Technologies, Paisley, UK) and RNeasy Mini kit (Qiagen, Hilden, Germany) including treatment with RNasefree DNase set (Qiagen) according the manufacturer's instructions. The quality of RNA was analyzed with an Agilent 2100 bioanalyzer (Agilent Technologies Inc, Palo Alto, Calif), and quantity was measured by a NanoDrop (Thermo Scientific, Waltham, Mass). The ASAP and BiKE databases are independent of each other, but several overlaps exist between the individual ASAP data sets: In ASAP, 223 different patients had microarray measurements made on aortic medial tissue, aortic adventitia, liver, and mammary artery. Information on sample size and distribution of all samples with both RNA expression measurements and DNA genotyping can be found in Table 1 .
Figure 1.
Observed test statistics for investigated SNPs compared with random sample SNPs. The y-axis shows the Ϫlog 10 (P) significance of associations between SNPs and the most significantly associated nearby genes using an additive model. The x-axis is the sorted rank of each y-axis value. Black dots show the distribution of P-values for the investigated set of risk-SNPs identified from the literature. Blue dots represent random equally sized samples of SNPs and the strongest association with expression of one of the genes within a 400-kb search window. There are no significant differences in distance between SNPs and genes in the risk-SNP group and the corresponding distances in groups of random SNPs. Red dots represent random equally sized samples of SNPs and the strongest association with the expression of 1 of the genes sampled from randomly selected 400 kb search windows. Each of the 2 random sampling sets has been repeated 10 times. For clarity, the plot has been cropped to maximally show a _log10(P) value of 7. This leaves out several highly significant data points but allows focus on the general trend of more significant P-values for SNPs identified in GWAS. 
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Genotyping and Expression Analysis
The BiKE and ASAP RNA samples were hybridized and scanned at the Karolinska Institute Affymetrix core facility. For samples from the BiKE biobank Affymetrix HG-U133 plus 2.0 arrays and protocols were used, whereas Affymetrix GeneChip Human Exon 1.0 ST arrays and protocols were used for samples from the ASAP biobank. For probe set and meta probe set level investigations, that is, the analysis of whole-gene variation with genotype, cel files were preprocessed using Robust Multichip Average (RMA) 7 normalization as implemented in the Affymetrix Power Tools 1.10.2 package apt-probeset-summarize. All expression measurements were log 2transformed as part of the RMA normalization. Using HG-U133 plus 2.0 arrays, all probe sets were included and using Exon 1.0 ST arrays the investigation was performed in the extended subset of Affymetrix meta probe sets. Expression of sex specific transcripts were checked for concordance with data base-registered sex. Microarray probes containing SNPs are potential sources of error. However, on investigation, it was found that results were largely similar with or without these probes. All presented expression data are filtered for probes containing known SNPs from build 131 of NCBI dbSNP.
DNA samples from ASAP and BiKE patients were genotyped using Illumina Human 610W-Quad Beadarrays at the SNP technology platform at Uppsala University. The GenomeStudio software from Illumina was used for genotype calling and quality control. The average call rate per SNP was 99.84%. Replicate genotyping of 12 samples showed an overall concordance of 99.99%. Data for 8 SNPs that had previously been genotyped with a taqman PCR-based method (Applied Biosystems Carlsbad, Calif) in 89 samples from the BiKE cohort showed only 1 discrepant genotype, corresponding to a concordance rate of 99.86%.
Of the 168 initially selected SNPs, 114 (67.5%) were either genotyped directly on the Beadarray or had a perfect proxy (linkage disequilibrium [LD] of R 2 ϭ1) that was genotyped. Most of the remaining SNPs (51) could be imputed using PLINK software with an INFO value of 0.8 or above. The investigated SNPs were in Hardy-Weinberg equilibrium at PϾ0.01. Information on the imputed SNPs and LD-block structures is available in online-only Data Supplement Table 1 . Of all SNPs, 31 were found to be linked in 13 groups with other investigated SNPs (at R 2 Ͼ0.8), effectively giving 148 different investigated loci. Each SNP is treated individually in Figure 1 . SNPs in high LD are indicated together in Table 2 .
Selection of Neighboring Genes
To reduce the multiple testing, a limited number of neighboring genes were selected for association testing with each SNP. These genes were selected to be harbored within a region of 400 kb centered on each SNP. This width of the selection window was based on the fact that none of the investigated SNPs were found to be in an LD of R 2 Ͼ0.8, with other SNPs further than 200 kb away (median distance was 34 kb) in the HapMap CEU population. This choice is further supported by previously published data in which the majority of associations are found within a 200-kb window. 4 All positions of genes are from ENSEMBL 56 (GRCh37 assembly), and all positions of SNPs are from ENSEMBL variation 56 (dbSNP130 assembly). 8 Data were retrieved using the biomaRt package, 9 available through the Bioconductor repository. 10
Statistics
All association tests between genotype and gene expression level were performed using additive (0-1-2) and dominant/recessive (0-0-1 and 0-1-1) models. The additive model encodes each heterozygote patient as 1 and each of the 2 homozygote types as 0 or 2. A linear model is fitted to the expression level of each gene, using this genotype value as effect. The additive model was not applied to genotypes with only 1 homozygote form present in a data set. The dominant/recessive models group the heterozygote samples with 1 of the homozygotes and compare the expression level of a gene using All loci with an association with the expression of a gene at PϽ0.005, using an additive model are listed. A few interesting examples with lower significance or significance under different models are also included. A complete list of all SNPs with association P values for all nearby genes in all data set under all 3 association models can be found in supporting information table S1. Presence in same LD block is defined as close to any SNP in LD of R 2 Ͼ0.6.
*Previously shown eQTL from Reference 6. 6
Student t test. Multiple testing issues are limited by a directed choice of risk-SNPs and the use of a narrow search window for nearby genes. On average for each data set, 703 tests were applied to 131 SNPs using an additive model. A P-value cutoff of 0.005 corresponds to an overall false discovery rate of 0.1, calculated using the qvalue package from Bioconductor. Another indication of false discovery rates, obtained from a more realistic background of random samplings of SNP associations can be found in Figure 1 . False-positive rates at PϽ0.005 calculated from these samplings are 0.022 for exon arrays and 0.038 for HG-U133 plus 2.0 arrays. This difference from standard false discovery rate probably is due to the interdependence of testing the same genes in similar tissues. In any case, we have sought to avoid a hard threshold for significance. Instead, we present and discuss all P-values as raw and unmodified.
Results
The risk-SNPs were selected from genome-wide association studies (GWAS) investigating cardiovascular risk factors for which relevant tissue were available to us. These included serum LDL, HDL, triglyceride concentrations, and waist circumference (liver), myocardial infarction, aneurysm formation, atherosclerosis, and hypertension (vessel wall, plaque). All larger studies of Caucasians catalogued under relevant trait headers in the Catalog of Published Genome-Wide Association Studies 11 were trawled, and SNPs were included in the analysis if they had been found to be significantly or borderline significantly associated with the phenotype according to the statistical considerations used by the authors of each article. 6, [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] A total of 168 SNPs were identified, but, after imputation, 166 SNPs remained to be studied. An overview of the included SNPs together with data on proxy selection, LD block size, and association with expression is provided in supporting information in online-only Data Supplement Table S1 . In general, the selected SNPs showed stronger associations with gene expression levels than expected by chance alone. In Figure 1 , the association trends are compared between GWAS risk-SNPs and random samples of SNPs. Here, the association of one group of randomly selected SNPs was related to the expression of nearby genes and another group of randomly selected SNPs was related to randomly selected genes. As motivated in the methods section, nearby genes were defined as being located within 200 kb of a SNP. Generally, SNPs showed stronger associations with the expression of nearby genes than with the expression of randomly selected genes, but the specific set of SNPs selected from GWAS showed much stronger associations. This finding supports the initial hypothesis that risk-SNPs frequently act by influencing the expression levels of nearby genes. Of all investigated risk-SNPs, 47 were associated with the expression level of a nearby gene at PϽ0.005 in 1 or more of the investigated tissue types.
Particularly strong associations were seen in the liver samples, but also plaque samples and the intimal/medial portions of the aortic samples showed association levels above those expected for randomly selected SNPs. The tissue distribution of associations depended on the phenotype investigated. The majority of risk-SNPs associated with lipid phenotypes were found to be associated with gene expression levels in the liver, and more than half of these SNP-expression level associations were confined to the liver only. SNPs associated with phenotypes that are more directly related to the vessel wall were more frequently associated with gene expression levels in vascular tissues (Figure 2) .
On the basis of the distance between SNPs and the associated genes, 4 different classes of associations between SNPs and gene expression levels emerged. Approximately half of the SNPs were located in close proximity to or within the associated genes ( Figure 3 ). However, in 22 instances, the SNPs were not located within Ͻ35 kb of the genes. Of these associations, 9 are explained by linked SNPs in closer proximity to the gene ( Figure 4A ). However, for 7 other associations, there were no SNPs in LD at R 2 Ͼ0.4 in closer proximity to the associated gene ( Figure 4B) . A fourth complex class of SNPs is exemplified by rs6450415 ( Figure  4C ). This SNP associates with the expression levels of MAP3K1, GPBP1 and MIER3 in mammary artery tissue at P-values between 0.0044 and 0.009. The expression levels of these 3 genes show high degree of correlation (Pearson correlation coefficient Ͼ0.75 for all pairwise comparisons), which, because of the proximity, is likely to indicate a coregulatory mechanism of the SNP. The 3 genes are found at distances of 157 kb and 136 kb centromeric and 121 kb telomeric from the risk-SNP, and, because there are no SNPs in LD of R 2 Ͼ0.4 further than 30 kb away, this observation is not explained by an LD-block. This finding is of general interest because there are several other similar observations, for example, the associations of the SNP rs413016 with SRR, Figure 2 . Tissue specificity relates to phenotype. Number of times SNPs are found to be associated with gene expression in a given tissue, stratified by the phenotype previously found to be associated with these SNPs. Association is based on the interpretation given in Table 2 . Basing association on a hard cutoff, such as PϽ0.005, gives a similar trend but omits cases of recessive/dominant effects and cases with interpreted clear high-significant dominance of 1 tissue type. Lipids phenotypes are defined as HDL, LDL, TG, or total cholesterol. Vessel wall-related phenotypes are broadly defined as anything related to diastolic blood pressure, internal left ventricular diastolic dimensions, left ventricular mass, systolic blood pressure, left ventricular systolic dysfunction, or left ventricular wall thickness. However, the trend is the same in each of these subsets when analyzed separately.
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SMG6, and METT10D, and those of rs6922269 with PLEKHG1 and MTHFD1L (see also Table 2 and online-only Data Supplement Table S2 ). The implication of the existence of four classes of SNP gene expression associations is that genes located next to identified risk-SNPs do not necessarily participate in the disease mechanism. It is of special clinical relevance to discuss examples of risk-SNPs associated with the important phenotype of myocardial infarction (MI). 12-14, 23,24 As shown in a previous analysis of this data set, no association with proximal gene expression is found for the chr9p21.3 locus. 25 In contrast, the rs646776 SNP shows a strong association with the expression level of SORT1 (Pϭ8.14e-62). This association has previously been shown in liver. 5, 6 Our present data show that the SORT1 association is remarkably liver-specific, even though SORT1 shows high expression levels in all the investigated tissues. An example of novel association with gene expression is seen for the rs6725887 SNP, which has previously been reported to be associated with MI, with WDR12 as the reported culprit gene. 14 As shown in Figure 4B , however, the expression of the NBEAL1 gene, located at a distance of 134 kb, gives a stronger association signal with the genotype of the rs6725887 SNP. This distance span is of the LD-block spanning class and the P-value for the association signal is Ͻ0.005 in all vascular tissues included in the analysis. The NBEAL1 gene encodes the neurobeachin-like 1 protein, which has previously only been implicated in glioma. 26 Our findings suggest it as a novel research target. Other MI-specific examples of novel SNP expression level associations are listed in Table 2 .
Discussion
GWAS provide valuable indications of novel potential pathophysiological mechanisms for complex diseases. However, it should be underscored that GWAS are designed to discover links between disease and genetic markers, not necessarily between disease and actual genes. In the present study, we show that the most proximal gene is often not the culprit gene. Also, an important observation in our study is the high degree of tissue specificity. The effects of the majority of SNPs associated with lipid levels were seen in liver tissue and many of them solely there. SNPs associated with MI showed gene expression associations that were specific for vessel wall tissue, particularly aortic intima/media. The corollary is that tissue diversity is essential for future eQTL studies. Tissue types thought to be involved in the pathogenesis of an investigated disease are of primary interest, but it cannot be excluded that broader investigations will uncover novel pathophysiological mechanisms.
Several SNPs did not show association with expression levels of any nearby genes. There are several explanations for how these SNPs could influence the first step of a mechanism, examples being alteration of protein sequence (directly or indirectly through linkage), expression changes in other tissues, not included in this analysis, or effects outside of the search window. Although 200 kb was the size of the largest LD block encountered in this study, we observed associations with the expression levels of genes outside the reach of LD blocks. Finally, more complex regulation patterns could be responsible. For example, mechanisms suggested to be responsible for the much-investigated chr9p21 ANRIL SNP Figure 3 . Tissue-specific association between genotype and expression level of all genes within a 400 kb search window. In each plot, the y-axis shows the Ϫlog 10 (P) calculated for the association between genotype and expression level using an additive model. The x-axis shows the data sets listed in Table 1 . In this table, n is also listed. Each colored line shows the association level for 1 gene across different tissue types. The relative expression level of a gene in the tissue type is indicated by the dot size. Relative location of genes, SNP, and LD boundaries are indicated by the map below each plot. Different shades of gray indicate the most distal SNPs in LD of R 2 0.8, 0.6, and 0.4, respectively. A, Simple example of the notation used in tissue specific plots: the rs1532085 and its association with the expression of LIPC. Because this is the only gene close to the SNP, there is only 1 colored line. As can be seen from the height of this line, the association is highly liver-specific. In addition, the dot sizes show that LIPC is only expressed in the liver. The rs1532085 SNP has previously been associated with HDL levels. 15 B, Example of association between a SNP and its harboring gene. The association between rs1167998 and the expression of DOCK7 is seen in plaque tissue only. This SNP has previously been associated with serum cholesterol and triglyceride (TG) concentrations. 15 association include miRNA and epigenetics, expression patterns limited temporally to discrete developmental stages, and a complex transcript isoform structure. 25, 27 An important promise of the GWAS is the ability to identify novel pathways of pathogenesis and eventually new concepts for therapy. Accurate knowledge of the functional consequences of genetic variation is essential to achieve this goal. The multiple instances where the associated gene is not the immediately obvious candidate gene for disease demonstrate the necessity of careful studies of genetic marker data as a first step toward application of GWAS knowledge in a clinical setting. Figure 3 for plot description. A, Example of long-range association that is a result of LD block span. The rs6725887 SNP is associated with the vessel wall expression of NBEAL1. The SNP-to-gene distance is 134 kb, but a perfect proxy is found inside the gene. This SNP has been found to be associated with risk of MI. 14 B, Example of longer-range association without more proximal SNPs in LD. The rs174570 SNP and the expression levels of C11orf9 are associated in liver. However, the SNP-to-gene distance is 41 kb. No other SNPs in LD of R 2 Ͼ0.4 are found closer to the gene. C, Example of a complex interaction. The rs6450415 SNP, previously associated with left ventricular mass, 20 associates with the expression of MIER3, GPBP1, and MAP3K1 in mammary artery.
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CLINICAL PERSPECTIVE
Over recent years, variations in the DNA sequence, so-called single nucleotide polymorphisms (SNPs), have been increasingly acknowledged as genetic modulators of the risk of developing cardiovascular disease. Several large-scale genome-wide association studies have identified hundreds of SNPs associated with cardiovascular disease or important risk factors. It is usually assumed that the gene located closest to the SNP site is the so-called "risk gene" responsible for the effect of the SNP, but this may not be true. In this investigation, we sought to identify the culprit genes likely to mediate the effect of SNPs associated with cardiovascular disease. By combining gene expression measurements in liver, plaque and vessel wall with 156 SNPs associated to cardiovascular disease, we demonstrate that the effect of SNPs are tissue-and phenotype-specific. Furthermore, in more than 20 instances, the culprit gene was not directly deducible from the location of the risk-SNP. An important promise of genome-wide association studies is the ability to identify novel pathobiological pathways and new concepts for therapy. To fully understand the role of SNPs in mediating disease and to develop novel treatments, accurate knowledge of the functional consequences of genetic variation is essential. The present study emphasizes the necessity of combining functional studies of genetic markers with association data to realize the full potential of current genomic research.
